ADCY6

ADCY6 is a calcium-inhibitable, membrane-bound adenylate cyclase that generates compartmentalized cAMP pools to regulate a wide range of physiological processes including cardiac function, renal water homeostasis, intestinal fluid secretion, airway ciliary length, peripheral nervous system myelination, and hepatic glucose output. Localized to lipid raft microdomains, AC6 forms functionally specialized signaling complexes—with AKAP79/150-anchored PKA for negative feedback termination of cAMP synthesis, with IP3R2 for binary cAMP-Ca²⁺ signaling junctions, and with CFTR at the apical surface of intestinal epithelia to drive cholera toxin–induced secretory diarrhea (PMID:16973443, PMID:18936250, PMID:29903911, PMID:12748066). In the kidney, AC6 is the predominant cyclase coupling vasopressin V2 receptor stimulation to water reabsorption, and in airway epithelia it controls ciliary length by suppressing AMPK-dependent autophagic degradation of the kinesin KIF19A (PMID:20466003, PMID:32683324). Notably, a catalytically dead AC6 mutant (D426A) retains the ability to reduce cardiac hypertrophy and apoptosis and to alter Ca²⁺ handling, demonstrating that key cardioprotective functions are independent of cAMP generation, while loss-of-function mutations in humans cause absence of peripheral myelin (PMID:21127130, PMID:24319099).

1. 2003 Medium

   Establishing that AC6 resides in lipid raft microdomains answered how calcium-dependent inhibitory signals from nAChRα7 are spatially coupled to AC6: raft localization is required for this regulation, defining AC6 as a compartment-specific signaling node.

   Evidence Sucrose gradient fractionation, co-immunoprecipitation, and cholesterol depletion in BAECs

   PMID:12748066

   Open questions at the time

   • Single lab; raft localization not confirmed by super-resolution imaging
   • nAChRα7–AC6 interaction not validated by reciprocal pull-down or proximity ligation
2. 2006 High

   Two parallel discoveries revealed how AC6 activity is terminated and how it controls a classic physiology paradox: AC6 forms a complex with AKAP79/150 that recruits PKA for feedback phosphorylation/inhibition of AC6, and AC6 (together with AC5) mediates the calcium-dependent suppression of renin secretion in juxtaglomerular cells.

   Evidence Co-IP plus live-cell cAMP imaging with PKA disruption in HEK293 cells; siRNA knockdown in primary juxtaglomerular cells, As4.1 cells, and isolated perfused kidney

   PMID:16973443 PMID:17068292

   Open questions at the time

   • Stoichiometry and structural basis of the AKAP79/AC6/PKA complex unknown
   • Relative contributions of AC5 vs AC6 to renin regulation not fully separated in vivo
3. 2008 High

   Demonstrating that AC6 selectively couples with IP3R2 to form cAMP junctions resolved how supra-threshold cAMP concentrations are delivered to a specific target without flooding the cytoplasm, establishing a binary signaling mode for cAMP-Ca²⁺ crosstalk.

   Evidence siRNA knockdown of AC6 and IP3R2, Ca²⁺ imaging, and co-immunoprecipitation in HeLa cells stimulated with PTH

   PMID:18936250

   Open questions at the time

   • Whether AC6–IP3R2 junctions exist in tissues beyond cell lines not tested
   • Structural determinants of AC6–IP3R2 selectivity unresolved
4. 2010 High

   Three studies collectively defined AC6's in vivo physiological roles and, critically, dissociated its catalytic activity from its cardioprotective effects: AC6 KO mice showed impaired vasopressin-mediated water reabsorption; a catalytically dead D426A mutant still reduced cardiac hypertrophy and apoptosis; and AC6 overexpression suppressed bleomycin-induced pulmonary fibrosis via β-adrenergic/prostacyclin cAMP signaling.

   Evidence AC6 KO mice (two lines) with DCE-MRI and metabolic cages; D426A mutagenesis with gene transfer in rat cardiac myocytes; AC6-transgenic mice in bleomycin fibrosis model

   PMID:20348281 PMID:20466003 PMID:21127130

   Open questions at the time

   • cAMP-independent cardioprotective mechanism of AC6 remains molecularly undefined
   • Antifibrotic function not tested with catalytically dead mutant
   • Identity of AC6 protein–protein interactions mediating cAMP-independent cardiac effects unknown
5. 2013 High

   Identification of a homozygous ADCY6 mutation causing absent peripheral myelin in humans, phenocopied by morpholino knockdown in zebrafish, established AC6 as essential for Schwann cell–mediated PNS myelination—the first Mendelian disease link for this gene.

   Evidence Whole-exome sequencing in affected family, TEM of sciatic nerve, zebrafish morpholino knockdown

   PMID:24319099

   Open questions at the time

   • Downstream myelination program controlled by AC6-generated cAMP in Schwann cells not delineated
   • Only one family reported; allelic spectrum unknown
6. 2018 High

   Showing that AC6 physically complexes with CFTR at the apical membrane of intestinal epithelia and is the dominant cyclase driving cholera toxin–induced fluid secretion answered which adenylyl cyclase isoform mediates secretory diarrhea.

   Evidence Co-IP, epithelium-specific AC6 KO mice, ligated ileal loop assay, intestinal spheroid CFTR activation

   PMID:29903911

   Open questions at the time

   • Whether AC6–CFTR interaction is direct or scaffolded not resolved
   • Therapeutic potential of AC6 inhibition in cholera not tested
7. 2019 High

   Identification of Purβ as a direct transcriptional activator of ADCY6 linked hepatic AC6 expression to gluconeogenesis, explaining how the glucagon/cAMP/PKA/CREB axis is sustained at the transcriptional level in diabetic liver.

   Evidence ChIP, luciferase reporter, and adenoviral KD/OE of Purβ in hepatocytes and db/db mice

   PMID:31918924

   Open questions at the time

   • Other transcription factors regulating ADCY6 in non-hepatic contexts not mapped
   • Whether Purβ regulation is specific to ADCY6 vs other ADCY isoforms unclear
8. 2020 High

   Demonstrating that AC6 controls airway ciliary length by inhibiting AMPK-dependent autophagic degradation of KIF19A revealed a non-canonical cyclase function linking cAMP signaling to autophagy and cytoskeletal regulation.

   Evidence Epithelium-specific AC6 KO mice, KIF19A quantification, autophagy flux assays, pharmacological AMPK modulation

   PMID:32683324

   Open questions at the time

   • Whether AC6–AMPK inhibition is direct or mediated by PKA/Epac not resolved
   • In vivo mucociliary clearance consequences not measured
9. 2023 Medium

   Phosphoproteomic profiling resolved how raft-localized AC6 and non-raft AC2 generate distinct downstream signaling networks from equivalent total cAMP, demonstrating that AC6-specific cAMP pools preferentially regulate autophagy, Ca²⁺/CaM, and Rho GTPase signaling.

   Evidence Isoform-specific overexpression in human airway smooth muscle with quantitative LC-MS/MS phosphoproteomics

   PMID:36926196

   Open questions at the time

   • Phosphoproteomic targets not validated by targeted mutagenesis
   • Single cell type studied; generalizability to other AC6-expressing tissues unknown

• The molecular basis of AC6's cAMP-independent cardioprotective activity—identified by the catalytically dead D426A mutant—remains unknown; the interacting partners, structural features, or scaffolding functions responsible have not been identified.
• No interactome or structural study of the D426A mutant performed
• Whether cAMP-independent functions extend to non-cardiac tissues untested
• AC6-specific inhibitors or activators for therapeutic use not developed